[Home ] [Archive]   [ فارسی ]  
:: Main In Press Current Issue All Issues Search register ::
Main Menu
Home::
Journal Information::
Editorial Board::
Articles archive::
For Authors::
For Reviewers::
Editorial Policy::
Registration::
Contact us::
::
..
Indexing

 

 

 

 

 
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Creative commons

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

..
:: Volume 2, Issue 4 (Winter 2002) ::
J Ardabil Univ Med Sci 2002, 2(4): 12-17 Back to browse issues page
Anti-HCV Seropositivity among Multiply Transfused Patients in Ardabil Province, 2000
Manoochehr Barak * , Nayereh Aminisani , Mehrdad Mirzarahimi , Seyedmorteza Shamshirgaran , Nategh Abbasgholizadeh
, m.barak@arums.ac.ir
Abstract:   (10112 Views)

 Background & Objective: Hepatitis C Virus is the most common cause of post-transfusion hepatitis. This study was conducted to evaluate the prevalence of hepatitis C in multiply transfused patients.

 Methods: 45 patients with B- thalassemia major, 4 patients with hemophilia and 1 patient with aplastic anemia were studied prospectively during 2000. An initial questionnaire was used to collect the data regarding age, sex, duration and interval of at blood translation family history and the type of blood product received and the date of first infusion and then a blood sample was taken for detection of antibody against HCV.

 Results: 62% of the subjects were male and 38% of them were female with the age range of 6 months- 29 years old. 92% of the patients used packed red blood cells. 27 patients had a positive family history of thalassemia and two seropositive patients (4%) had thalassemia. Duration and mean amount of blood transfused were significantly higher in patients with HCV infection. Data analysis showed now significant relationship among variables of the study and hepatitis C cases.

 Conclusions: It is concluded that multiply transfused thalassemic patients are at high risk for HCV infection. Thus, routine screening of blood and anti- HCV test in these patients is necessary.

Keywords: HCV, Thalassemia, Transfusion
Full-Text [PDF 961 kb]   (1861 Downloads)    
Type of Study: article | Subject: Special
Received: 2001/07/2 | Accepted: 2002/04/29 | Published: 2003/06/14
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Barak M, Aminisani N, Mirzarahimi M, Shamshirgaran S, Abbasgholizadeh N. Anti-HCV Seropositivity among Multiply Transfused Patients in Ardabil Province, 2000. J Ardabil Univ Med Sci 2002; 2 (4) :12-17
URL: http://jarums.arums.ac.ir/article-1-543-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 2, Issue 4 (Winter 2002) Back to browse issues page
مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.19 seconds with 41 queries by YEKTAWEB 4623